Vivo Capital, LLC
Vivo Capital, LLC is a global healthcare investment firm headquartered in Palo Alto, California. The firm was founded in 1996 and specializes in private equity and venture capital, focusing on investments in healthcare, pharmaceuticals, and biotech sectors. Employing approximately 67 professionals, Vivo Capital manages substantial capital from institutional investors, family offices, and high net worth individuals, and serves clients worldwide.
Investment Strategy
Vivo Capital pursues both private equity and venture capital investments, targeting high-growth healthcare and life sciences companies. The firm invests across stages from early innovation to growth and expansion, focusing on pharmaceuticals, medical devices, and healthcare services. Its strategy blends rigorous scientific diligence with deep sector expertise, seeking to foster technological advancements and value creation in both US and Asian markets.
Latest 13F Filing Activity
Vivo Capital, LLC filed their most recent 13F report on Jun 30, 2025 disclosing 41 equity positions with a total 13F market value of $977M. The fund increased holdings in Cidara Therapeutics, Inc., Verona Pharma PLC, Sinovac Biotech LTD. among other positions. Vivo Capital, LLC reduced exposure to Unicycive Therapeutics, Geron Corp., Regulus Therapeutics Inc. among others.
Top Holdings
Equity Positions (41)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
S SLNO | Soleno Therapeutics Inc | 33.94% | $331.6M | 3,958,294 | $36.16 | $83.78 | +$13.1M |
V VRNA | Verona Pharma PLC | 13.49% | $131.8M | 1,393,432 | $6.97 | $94.58 | +$40.4M |
C CDTX | Cidara Therapeutics, Inc. | 6.54% | $63.9M | 1,311,425 | $37.26 | $48.71 | +$49.1M |
G GERN | Geron Corp | 3.93% | $38.4M | 27,225,292 | $1.91 | $1.41 | -$4.9M |
S SINX | Sinovac Biotech Ltd. | 3.91% | $38.2M | 5,903,000 | $0.00 | $0.00 | +$38.2M |